The FDA announced a revision to the labeling for the Ortho Evra birth-control patch, warning that women taking the drug may be exposed to 60% more estrogen than if they were taking a typical 35 ...
- UNDATED HANDOUT PHOTO - Johnson & Johnson won U.S. approval to sell Ortho Evra, the first contraceptive skin patch, the Food and Drug Administration said November 20, 2001. The patch releases ...
A panel of federal health advisers said Friday that a birth control patch from Johnson & Johnson probably carries a higher risk of blood clots than older drugs, but should remain available as an ...
September 21, 2006 — The US Food and Drug Administration (FDA) and Ortho-McNeil Pharmaceutical (a Johnson & Johnson company) have notified healthcare professionals regarding changes to the safety ...
Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) approved new labeling today regarding the increased level of estrogen exposure associated with use of an ethinyl estradiol/norelgestromin ...
Getting your Trinity Audio player ready... ADELPHI, Md. — A panel of federal health advisers said Friday that a birth-control patch from Johnson & Johnson probably carries a higher risk of blood clots ...
Preliminary data on the risk of blood clots with the Ortho Evra contraceptive patch warrant further analysis but no immediate regulatory action, the FDA said today.Ortho Women’s Health, a unit of ...
FORT WORTH, Texas, Sept. 21 /PRNewswire/ -- The U.S. Food and Drug Administration's announcement that additional warnings have been added to the label for Johnson & Johnson's (NYSE: JNJ) Ortho Evra ...
NEW YORK, Sept. 21, 2006 (PRIMEZONE) -- Parker & Waichman, LLP (www.yourlawyer.com) announced that it believes a new study provides further evidence that Ortho Evra is dangerous and should be recalled ...
PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE™ (Norelgestromin / Ethinyl Estradiol ...
The lawsuit over Ortho Evra is one of hundreds filed nationwide, company officials said. Katy McKellips Braman was 17 when she was prescribed the Ortho Evra patch in 2004, according to the lawsuit.
Mylan announced that it has launched Xulane (Norelgestromin/Ethinyl Estradiol Transdermal System) 150/35mcg per day, the generic version of Janssen’s Ortho Evra transdermal patch. Mylan received final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results